There are cancers unique to women, such as gynecologic cancers and the majority of breast cancers. Gynecologic cancer is any cancer that starts in a woman’s reproductive organs. There are five main types of gynecologic cancers: cervical, ovarian, uterine, vaginal and vulvar.
We are currently investigating experimental medications to treat women’s cancers, including gynecologic cancers and triple negative breast cancer.
Gynecologic cancers begin in different places within a woman’s pelvis, which is the area below the stomach and in between the hipbones. Each gynecologic cancer is unique and has its own signs, symptoms and risk factors.
Triple negative breast cancer accounts for approximately 15-20% of breast cancers diagnosed worldwide. It is more common in younger women, African American women and more common in Hispanic women than non-Hispanic women.
There is much research focused on identifying unique characteristics of the many different types of cancers. Terms such as personalized, targeted, and precision medicine are often used in cancer related communications. These terms refer to all the research and discoveries that support identification of treatments based on unique characteristics of your particular cancer. You may also have heard the term ‘biomarker’. Through research, many biomarkers (also called ‘tumor markers’ when referring to cancer) have been identified and reflect some of the unique characteristics in your blood, urine and/or tissue. Some biomarkers that you may have heard of in women’s cancers are types of molecules, such as the following, with examples:
These all indicate something about your condition and may help your doctor address your unique needs. Our research studies continue to work to build on the currently knowledge of biomarkers, by investigating the potential of additional biomarkers to improve care.
Thank you for Considering a Clinical Trial
Below you will find clinical trials that are either currently recruiting patients (noted as Recruiting) or starting to recruit patients soon (noted as Not Yet Recruiting).
Here are some options for you to find more information:
An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors
A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)
Get updates on clinical trials
Read the stories below and send us your own.
"I am thankful that I had friends & family to lean on – I don’t like being vulnerable, but being so was freeing in the end." ...
"I am thankful that I had friends & family to lean on – I don’t like being vulnerable, but being so was freeing in the end." ...View Story
"I noticed a red spot on my shoulder and didn't think too much about it, but after a few more days it didn't change. Nancy recommended that I probably ought to get it checked"
"I noticed a red spot on my shoulder and didn't think too much about it, but after a few more days it didn't change. Nancy recommended that I probably ought to get it checked"View Story
"They want you to be as safe as possible. So as soon as they notice something is off, they will tell you. And you have the option of saying, 'OK, I'm out.'"
"They want you to be as safe as possible. So as soon as they notice something is off, they will tell you. And you have the option of saying, 'OK, I'm out.'"View Story
"The medical oncologist did lay out exactly what was going to happen if I did go through this clinical trial, so there weren't any surprises"
"The medical oncologist did lay out exactly what was going to happen if I did go through this clinical trial, so there weren't any surprises"View Story
Bristol-Myers Squibb is not affiliated with the creators of this content. The information provided here is for informational purposes only and is not meant to replace a physician's medical advice or imply endorsement. Content in this video may speak to medical topics that are not necessarily related to clinical trials.
Used with permission of the Society of Gynecologic Oncology and Foundation for Women’s Cancer. SGO and FWC permission does not constitute endorsement of company products or services.Gynecologic Cancer Clinical Trials: What This Means for You 19:00
Just as cancer affects your physical health, it can bring up a wide range of feelings you’re not used to dealing with. It can also make existing feelings seem more intense. They may change daily, hourly, or even minute to minute. This is true whether you’re currently in treatment, done with treatment, or a friend or family member. These feelings are all normal.
Often the values you grew up with affect how you think about and cope with cancer. For example some people:
Whatever you decide, it's important to do what's right for you and not to compare yourself with others. Your friends and family members may share some of the same feelings. If you feel comfortable, share this information with them.
More about Feelings and Cancer, originally published by the National Cancer Institute.
If you are helping your family member or friend through cancer treatment, you are a caregiver. This may mean helping with daily activities such as going to the doctor or making meals. It could also mean coordinating services and care. Or it may be giving emotional and spiritual support. The tips below are for most cancer caregivers. But there are also more details available for caregivers dealing with advanced cancer, caregiving after treatment ends, for parents with a child with cancer, and for teens with a family member with cancer.
Selected Support Organizations
Bristol-Myers Squibb is not affiliated with nor endorses any of the listed organizations. The information/links provided by Bristol-Myers Squibb are meant for informational purposes only and are not meant to replace a physician's medical advice or imply endorsement.